Systems and methods of selecting compounds that induce conformational changes in mutant cereblon
AssigneeBristol-Myers Squibb Company
InventorsMary E. Matyskiela, Philip Paul Chamberlain, Gabriel C. Lander, Edmond R. Watson
Life of this patent
Estimating the term…
Abstract
Provided herein are systems and methods for screening and analyzing compounds based upon the elucidation of the interaction among cereblon, its substrates and certain compounds or agents. As an example, a system and method can include a computational model that mimics in silico the cereblon protein. Also provided herein are systems and methods for identifying a compound that induces a conformational change in Cereblon, and in particular P98A mutant cereblon.
Claims20
A method of identifying a compound that induces a conformational change in P98A mutant Cereblon (P98A CRBN), wherein the method comprises:
- (a) contacting the compound with P98A CRBN;
- and
- (b) assessing the P98A CRBN for a conformational change;
- wherein a P98A CRBN conformational change is indicative of a compound that induces the P98A CRBN conformational change.
A method of identifying a compound that induces a conformational change in P98A mutant Cereblon (P98A CRBN), wherein the method comprises:
- accessing biophysical and dynamics data for P98A CRBN;
- analyzing the biophysical and dynamics data to identify one or more potential allosteric sites on P98A CRBN;
- computationally screening a plurality of chemical compounds to determine a binding energy between each of the subset of allosteric sites and each of the plurality of chemical compounds;
- computationally modeling the effect of the chemical compounds binding to each of the plurality of allosteric sites;
- quantifying each of a plurality of conformations of P98A CRBN while bound to the chemical compounds and while not bound to the compounds;
- ranking the compounds based on achieving a conformation change in P98A CRBN;
- and selecting a subset of top ranking chemical compounds comprising a potential compound that induced a conformational change in P98A CRBN.
A method of identifying a compound that induces a conformational change in P98A mutant Cereblon (P98A CRBN), wherein the method comprises:
- (a) using structural information describing the structure of P98A CRBN;
- (b) performing a molecular dynamics (MD) simulation of the structure;
- (c) using a clustering algorithm to identify dominant conformations of the structure from the MD simulation;
- (d) selecting the dominant conformations of the structure identified from the clustering algorithm;
- (e) providing structural information describing conformers of one or more compounds;
- (f) using a docking algorithm to dock the conformers of the one or more compounds of step (e) to the dominant conformations of step (d);
- (g) identifying a plurality of preferred binding conformations for each of the combinations of protein and compound;
- (h) optimizing the preferred binding conformations using scalable MD;
- and
- (i) determining if the compound causes a conformation change in P98A CRBN in the preferred binding conformations;
- wherein if the compound causes a conformational change in the preferred binding conformations, the compound is identified;
- or
- wherein if the compound does not causes a conformational change in the preferred binding conformations, the compound is not identified;
- and
- wherein said steps (a) through (i) are executed on one or more processors.
Dependencies are inferred from the claim text.